Zobrazeno 1 - 10
of 1 885
pro vyhledávání: '"Erythropoiesis stimulating agents"'
Autor:
Chaewon Kang, Jinyoung Han, Seongmin Son, Sunhwa Lee, Hyunjeong Baek, Daniel Duck-Jin Hwang, Ji In Park
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Patients with end-stage kidney disease (ESKD) frequently experience anemia, and maintaining hemoglobin (Hb) levels within a targeted range using erythropoiesis-stimulating agents (ESAs) is challenging. This study introduces a gated recurrent
Externí odkaz:
https://doaj.org/article/09be82e558bb476596da37c2d5c60a90
Publikováno v:
INNOVATIONS in Pharmacy, Vol 15, Iss 4 (2024)
Background: Anemia is a significant global public health issue, and it is associated with lethargy, weakness, tiredness, and shortness of breath. Erythropoietin stimulating agents (ESAs) are recombinant / synthetic erythropoietin and can increase hem
Externí odkaz:
https://doaj.org/article/a146389ab9724305b1ecf059746ac601
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1563-1575 (2024)
Sari Mishina,1 Yuichiro Ito,1 Takumi Lee,1 Toshiaki Murofushi,2 Yoshiyuki Uetake,2 Tadao Akizawa3 1Astellas Pharma Inc, Tokyo, Japan; 2INTAGE Healthcare Inc, Tokyo, Japan; 3Division of Nephrology, Department of Medicine, Showa University School of Me
Externí odkaz:
https://doaj.org/article/48ef6532a21e414b9cd51799e69e3108
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Srdjan Nikolovski, Branislava Medic Brkic, Katarina Savic Vujovic, Ivana Cirkovic, Nina Jovanovic, Bhavana Reddy, Omer Iqbal, Chongyu Zhang, Jawed Fareed, Vinod Bansal
Publikováno v:
Diagnostics, Vol 14, Iss 21, p 2406 (2024)
Background/Objectives: Besides a multitude of consequences patients on chronic renal replacement therapy have, anemia is one of the most prominent factors making a significant number of patients dependent on erythropoiesis-stimulating agent (ESA) the
Externí odkaz:
https://doaj.org/article/ae9fb517c87440c6886608e4636cd847
Autor:
Piotr Bartnicki
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1884 (2024)
Anemia plays an important role in chronic kidney disease (CKD) progression because it worsens the quality of life and increases the risk of cardiovascular complications in CKD patients. In such cases, anemia is mainly caused by endogenous erythropoie
Externí odkaz:
https://doaj.org/article/ded45b53ca4c4f9a841fb903da62b361
Publikováno v:
Nefrología, Vol 43, Iss 5, Pp 562-574 (2023)
Resumen: Antecedentes y objetivo: Los estudios sobre la prevalencia de anemia en enfermedad renal crónica (ERC) en adultos no en diálisis (ERC-ND) y en programa de diálisis (ERC-D) en España no son recientes, o se centran en ciertos subgrupos. El
Externí odkaz:
https://doaj.org/article/61e3d46685054601abb33ab29aa1c52f
Autor:
José Portolés, Alejandro Martín-Malo, Leyre Martín-Rodríguez, Gema Fernández-Fresnedo, Patricia De Sequera, J. Emilio Sánchez, Alberto Ortiz-Arduan, Aleix Cases
Publikováno v:
Nefrología, Vol 43, Iss 5, Pp 517-530 (2023)
Resumen: La anemia es una complicación frecuente de la enfermedad renal crónica (ERC) y se asocia con una disminución en la calidad de vida y a un mayor riesgo de transfusiones, de morbimortalidad y de progresión de la ERC. El Grupo de Trabajo en
Externí odkaz:
https://doaj.org/article/7506df4de55c4832ad8fd08c5661d452
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Anemia induced by chronic kidney disease (CKD) has multiple underlying mechanistic causes and generally worsens as CKD progresses. Erythropoietin (EPO) is a key endogenous protein which increases the number of erythrocyte progenitors that mature into
Externí odkaz:
https://doaj.org/article/3ee716ba243346cf902172bce3b841d7
Autor:
Fliser D, Mata Lorenzo M, Houghton K, Ainsworth C, Blogg M, González de Antona Sánchez E, Portoles J
Publikováno v:
International Journal of Nephrology and Renovascular Disease, Vol Volume 16, Pp 115-129 (2023)
Danilo Fliser,1 Maria Mata Lorenzo,2 Katherine Houghton,3 Claire Ainsworth,3 Martin Blogg,2 Elena González de Antona Sánchez,4 Jose Portoles5 1Saarland University Medical Center, Homburg, Germany; 2Astellas Pharma Europe Ltd., Addlestone, UK; 3RTI
Externí odkaz:
https://doaj.org/article/8e1948fd45b54e12ac5251e9360431d0